| P50 | author | Peter M. Chumakov | Q59158415 |
| | Boris Kopnin | Q68052199 |
| P2093 | author name string | Larissa S Agapova | |
| | Julia L Volodina | |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| | Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts | Q22254223 |
| | Protein binding and signaling properties of RIN1 suggest a unique effector function | Q24319548 |
| | Genetic instabilities in human cancers | Q28131826 |
| | Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members of the Ras subfamily | Q28142888 |
| | Mechanisms of regulating the Raf kinase family | Q28183716 |
| | Targeting RAS signalling pathways in cancer therapy | Q28201363 |
| | RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis | Q28207629 |
| | Raf-1 activates MAP kinase-kinase | Q28211351 |
| | Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras | Q28238120 |
| | Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability | Q28612074 |
| | The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 |
| | Cyclin-dependent kinases: engines, clocks, and microprocessors | Q29614786 |
| | Universal control mechanism regulating onset of M-phase | Q29616481 |
| | Cell cycle control and cancer | Q29617536 |
| | Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells | Q29618480 |
| | Ras superfamily monomeric G proteins in carcinoma cell motility | Q30310335 |
| | Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos | Q30476162 |
| | DNA damage: Chk1 and Cdc25, more than meets the eye. | Q31858938 |
| | Ras caught in another affair: the exchange factors for Ral. | Q33540078 |
| | The role of phosphoinositide 3-kinase lipid products in cell function | Q33543235 |
| | Understanding Ras: 'it ain't over 'til it's over'. | Q33877218 |
| | Regulation of the G2/M transition by p53. | Q33943437 |
| | Roles of the mitotic inhibitors Wee1 and Mik1 in the G(2) DNA damage and replication checkpoints | Q33967177 |
| | Ras and Rho GTPases: a family reunion | Q34073399 |
| | Ras proteins in the control of the cell cycle and cell differentiation | Q34090530 |
| | Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents | Q34188494 |
| | Ras effectors: buying shares in Ras plc. | Q34258507 |
| | Wee1-dependent mechanisms required for coordination of cell growth and cell division | Q34277706 |
| | Checking out the G(2)/M transition. | Q34282259 |
| | Cdc2 regulatory factors | Q34320243 |
| | Ras and Rho regulation of the cell cycle and oncogenesis | Q34326213 |
| | Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts | Q34418354 |
| | The RASputin effect | Q34787093 |
| | Distinct requirements for Ras oncogenesis in human versus mouse cells | Q34787097 |
| | A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? | Q35069175 |
| | Clinical, cellular, and molecular aspects of cancer invasion | Q35094102 |
| | Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance | Q35179100 |
| | Ral-GTPases: approaching their 15 minutes of fame | Q35187818 |
| | The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle | Q35379903 |
| | PI3K/Akt and apoptosis: size matters | Q35603373 |
| | The dark side of Ras: regulation of apoptosis | Q35603375 |
| | The 14-3-3 cancer connection | Q35635340 |
| | Targeting the checkpoint kinases: chemosensitization versus chemoprotection | Q35679781 |
| | Signaling pathways in Ras-mediated tumorigenicity and metastasis. | Q36219180 |
| | Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells | Q36237256 |
| | Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation | Q36556010 |
| | Ral promotes anchorage-independent growth of a human fibrosarcoma, HT1080. | Q38304533 |
| | The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells | Q40387562 |
| | Chromosomal rearrangements involving telomeric DNA sequences in Balb/3T3 cells transfected with the Ha-ras oncogene. | Q40761521 |
| | P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints | Q40952393 |
| | The post-translational modifications of Ral and Rac1 are important for the action of Ral-binding protein 1, a putative effector protein of Ral. | Q41103610 |
| | Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes | Q41554941 |
| | MAPK mediates RAS-induced chromosome instability | Q42807220 |
| | Chemical cross-linking of drugs to DNA. | Q43700938 |
| | Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. | Q43918911 |
| | RAS oncogenes: the first 30 years. | Q55036584 |
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA damage | Q5205747 |
| P304 | page(s) | 36382-36389 | |
| P577 | publication date | 2004-06-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint | |
| P478 | volume | 279 | |